Community/Retail

The FDA today approved a drug previously granted Orphan Drug Designation for the treatment of gastric cancer after prior chemotherapy.

The vast majority of the 116 US Representatives who cosponsored legislation supporting provider status for pharmacists were reelected to Congress yesterday, according to a Pharmacy Times analysis of midterm election results.

Allergy & Asthma Network today announced a unique collaboration at the ACAAI's 2014 Annual Scientific Meeting in Atlanta. Both membership organizations will combine their specialized expertise and skills to help patients manage chronic conditions while updating health care professionals, pharmacies, and government officials about current best practices.

The Sheriff's Office in San Mateo County, California, is searching for a man suspected of robbing at least 6 pharmacies in San Francisco at gunpoint while allegedly dressed up as a clown.

An experimental ovarian cancer treatment failed to demonstrate statistically significant improvements in overall survival during a phase 3 trial.

North Dakota voters rejected a measure on yesterday's ballot to abolish a law that requires a licensed pharmacist to hold majority ownership of any pharmacy in the state.

With concerns of a potential Ebola outbreak in the United States still heightened, a pharmaceutical disaster response group is readying pharmacists with a series of resources on the virus.

Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, today announced the launch of Paricalcitol Injection, a generic version of AbbVie's Zemplar®. Hospira obtained U.S. Food and Drug Administration (FDA) approval of paricalcitol on Oct. 21 and launched the product Nov. 1.

Allergan, Inc. today commented on the ruling in the United States District Court for the Central District of California in the Company's federal securities litigation against Valeant Pharmaceuticals International, Inc., Pershing Square Capital Management, L.P. and its principal, William A. Ackman.

The new Diabetes Health Coach creates a personalized experience designed to help people living with diabetes improve their diabetes management.

Actavis plc, a leading global specialty pharmaceutical company, today announced that Chief Financial Officer R. Todd Joyce will retire from Actavis in early 2015. To ensure a smooth transition, the Company said Mr. Joyce will continue as the Company's CFO until a successor is named. Actavis has engaged a leading executive search firm to identify a successor.

The first buccal film formulation of buprenorphine and naloxone is anticipated to reach retail pharmacies by the end of this week, offering a new treatment option to the more than 2.5 million opioid-dependent patients in the United States.

The National Community Pharmacists Association applauds the Department of Labor ERISA Advisory Council for voting unanimously yesterday to recommend that DOL extend existing financial disclosure requirements to pharmacy benefit managers.

Commonly prescribed, older drugs for arthritis and pain may increase the risk of death from stroke.

The AHA is proud to stand side-by-side with the people of Berkeley as they become the first city in our nation to take on a bold initiative that will provide further evidence to the effectiveness of taxing sugary drinks at a penny per ounce.

The iPhone Health App provides a new tool for patients to keep track of important medical information that first responders can access.

The FDA is reviewing a regulatory application to add an asthma indication to Boehringer Ingelheim's chronic obstructive pulmonary disease treatment, tiotropium bromide.

The FDA has expanded its approval of Protein Sciences Corp's Flublok influenza vaccine to cover patients aged 50 years and older, thus permitting its use in all adults.

The National Association of Boards of Pharmacy released its "Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2014."

Dispensing generic hormonal therapies instead of their brand-name counterparts increases breast cancer patients' life-saving medication adherence by 50%.

In a head-to-head study, aripiprazole treatment from H. Lundbeck A/S and Otsuka America Pharmaceutical Inc. showed superior effectiveness to Janssen's paliperidone palmitate treatment in adult patients with schizophrenia.

A North Carolina District Attorney will announce next week whether he will pursue the death penalty against 2 men charged with beating a University of North Carolina Eshelman School of Pharmacy professor to death.

A comprehensive, policy-driven approach to decreasing food access disparities is needed to improve disabled Americans' diets.

An investigational HIV drug developed by Merck exhibited a strong overall safety and efficacy profile in a recently completed phase 2b study.

AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into an agreement to acquire Definiens, a privately-held company that has pioneered a world-leading imaging and data analysis technology, known as Tissue Phenomicsâ„¢, which dramatically improves the identification of biomarkers in tumour tissue.